Drug Type Synthetic peptide vaccine, Prophylactic vaccine |
Synonyms VSV based covid 2019 vaccine, VSV SARS 2 (+G) vaccine, VSV-SARS-2 vaccine |
Target |
Action inhibitors |
Mechanism SARS-CoV-2 S protein inhibitors(SARS-CoV-2 S protein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| COVID-19 | Preclinical | United States | 06 Apr 2022 |





